Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hemorrhagic Stroke l: Introduction

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...

Hemorrhagic Stroke ll: Pathophysiology

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...

Blood Transfusion and Agglutination

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...

Arboviral Encephalitis

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...

Hepatitis

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Improvement of erythropoietin bioassay.]

Klinicheskaia laboratornaia diagnostika·2019

Same author

[EBOLA FEVER].

Zhurnal mikrobiologii, epidemiologii i immunobiologii·2019

Same author

An experience in the clinical use of specific immunoglobulin from horse blood serum for prophylaxis of Ebola haemorrhagic fever.

Voprosy virusologii·2018

Same author

[Promising approaches of antiviral therapy of hemorrhagic fevers].

Zhurnal mikrobiologii, epidemiologii i immunobiologii·2014

Same author

[Study of sensitivity of laboratory animals to a causative agent of argentine hemorrhagic fever].

Zhurnal mikrobiologii, epidemiologii i immunobiologii·2014

Same author

[Experimental assessment of the possible significance of argasid ticks in preserving the natural foci of West Nile virus infection].

Meditsinskaia parazitologiia i parazitarnye bolezni·2013

Search research articles

Related Experiment Video

Updated: May 21, 2026

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013

[Argentine hemorrhagic fever].

V A Markin, V B Pantiukhov, V I Markov

Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii

|June 15, 2012

Summary

This summary is machine-generated.

Argentine hemorrhagic fever (AHF) is a severe disease caused by the Junin virus. This review covers its epidemiology, diagnosis, treatment, and prevention, offering insights for Russia.

More Related Videos

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Published on: November 3, 2023

Developing a Clinically Relevant Hemorrhagic Shock Model in Rats

Developing a Clinically Relevant Hemorrhagic Shock Model in Rats

Published on: March 22, 2024

Related Experiment Videos

Last Updated: May 21, 2026

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock

Published on: November 3, 2023

Developing a Clinically Relevant Hemorrhagic Shock Model in Rats

Developing a Clinically Relevant Hemorrhagic Shock Model in Rats

Published on: March 22, 2024

Area of Science:

Virology
Epidemiology
Pathogenesis

Context:

Argentine hemorrhagic fever (AHF) presents significant public health challenges.
The Junin virus is the etiological agent responsible for AHF.
Understanding AHF is crucial for disease control and prevention.

Purpose:

To provide a comprehensive overview of Argentine hemorrhagic fever.
To detail the epidemiology, etiology, and clinical manifestations of AHF.
To examine diagnostic, therapeutic, and preventive strategies for AHF.

Summary:

This review examines the epidemiology, etiology, clinical presentation, and pathogenesis of Argentine hemorrhagic fever (AHF), focusing on the Junin virus.
Diagnostic methods including virological, serological, immunochemical, and molecular-biological techniques are discussed.
Etiotropic therapy, vaccination, and protective measures for the Russian Federation population are explored.

Impact:

Provides a foundational understanding of Argentine hemorrhagic fever for researchers and clinicians.
Highlights key diagnostic and therapeutic approaches for effective patient management.
Offers guidance for developing public health strategies to prevent AHF outbreaks.